
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Jan 08, 2026 02:48 am UTC| Law Politics Business Health
A federal appeals court has blocked a Trump administration initiative that would have required hospitals serving low-income Americans to pay full prices upfront for certain high-cost prescription drugs before receiving...

Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Jan 06, 2026 02:27 am UTC| Business Health
Danish pharmaceutical giant Novo Nordisk has officially launched its once-daily Wegovy weight-loss pill in the United States, intensifying competition in the rapidly growing obesity drug market. The oral medication,...

Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Dec 31, 2025 01:51 am UTC| Business Health
Novo Nordisk and Eli Lilly are significantly lowering prices of their blockbuster obesity drugs Wegovy and Mounjaro in China, a move aimed at expanding access in one of the worlds fastest-growing weight-loss markets and...

Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Dec 31, 2025 01:47 am UTC| Governance Business Health
Vanda Pharmaceuticals has received approval from the U.S. Food and Drug Administration (FDA) for its drug tradipitant, branded as Nereus, marking the first new FDA-approved treatment for motion-induced vomiting in more...

Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Dec 30, 2025 10:50 am UTC| Business Health
Novo Nordisk and Eli Lilly are reducing prices for their widely used obesity medications, Wegovy and Mounjaro, in China, a move that could significantly expand patient access in one of the worlds largest pharmaceutical...

Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Dec 30, 2025 02:39 am UTC| Business Health
Royalty Pharma Plc (NASDAQ: RPRX) shares rose 1.5% in after-hours trading on Monday after the company announced it had acquired the final portion of PTC Therapeutics remaining royalty interest in Evrysdi, a leading spinal...

Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Dec 25, 2025 02:04 am UTC| Business Health
French pharmaceutical giant Sanofi has announced plans to acquire U.S.-based biotech company Dynavax Technologies in a deal valued at approximately $2.2 billion (1.9 billion). The acquisition, agreed on Wednesday, is aimed...